IBDEI0I2 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8360,0)
 ;;=N25.81^^35^442^44
 ;;^UTILITY(U,$J,358.3,8360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8360,1,3,0)
 ;;=3^Hyperparathyroidism,Secondary to Renal
 ;;^UTILITY(U,$J,358.3,8360,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,8360,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,8361,0)
 ;;=E27.40^^35^442^4
 ;;^UTILITY(U,$J,358.3,8361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8361,1,3,0)
 ;;=3^Adrenocortical Insufficiency,Unspec
 ;;^UTILITY(U,$J,358.3,8361,1,4,0)
 ;;=4^E27.40
 ;;^UTILITY(U,$J,358.3,8361,2)
 ;;=^5002742
 ;;^UTILITY(U,$J,358.3,8362,0)
 ;;=E29.1^^35^442^50
 ;;^UTILITY(U,$J,358.3,8362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8362,1,3,0)
 ;;=3^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,8362,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,8362,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,8363,0)
 ;;=E89.0^^35^442^53
 ;;^UTILITY(U,$J,358.3,8363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8363,1,3,0)
 ;;=3^Hypothyroidism,Post Surgical
 ;;^UTILITY(U,$J,358.3,8363,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,8363,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,8364,0)
 ;;=M85.80^^35^442^81
 ;;^UTILITY(U,$J,358.3,8364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8364,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,8364,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,8364,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,8365,0)
 ;;=M85.89^^35^442^80
 ;;^UTILITY(U,$J,358.3,8365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8365,1,3,0)
 ;;=3^Osteopenia,Mult Sites
 ;;^UTILITY(U,$J,358.3,8365,1,4,0)
 ;;=4^M85.89
 ;;^UTILITY(U,$J,358.3,8365,2)
 ;;=^5014495
 ;;^UTILITY(U,$J,358.3,8366,0)
 ;;=R94.6^^35^442^1
 ;;^UTILITY(U,$J,358.3,8366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8366,1,3,0)
 ;;=3^Abnormal Thyroid Function Studies
 ;;^UTILITY(U,$J,358.3,8366,1,4,0)
 ;;=4^R94.6
 ;;^UTILITY(U,$J,358.3,8366,2)
 ;;=^5019743
 ;;^UTILITY(U,$J,358.3,8367,0)
 ;;=Z78.0^^35^442^69
 ;;^UTILITY(U,$J,358.3,8367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8367,1,3,0)
 ;;=3^Menopausal
 ;;^UTILITY(U,$J,358.3,8367,1,4,0)
 ;;=4^Z78.0
 ;;^UTILITY(U,$J,358.3,8367,2)
 ;;=^5063327
 ;;^UTILITY(U,$J,358.3,8368,0)
 ;;=60100^^36^443^1^^^^1
 ;;^UTILITY(U,$J,358.3,8368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8368,1,2,0)
 ;;=2^BIOPSY OF THYROID
 ;;^UTILITY(U,$J,358.3,8368,1,4,0)
 ;;=4^60100
 ;;^UTILITY(U,$J,358.3,8369,0)
 ;;=20220^^36^443^2^^^^1
 ;;^UTILITY(U,$J,358.3,8369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8369,1,2,0)
 ;;=2^BONE BIOPSY TROCAR/NEEDLE
 ;;^UTILITY(U,$J,358.3,8369,1,4,0)
 ;;=4^20220
 ;;^UTILITY(U,$J,358.3,8370,0)
 ;;=10021^^36^443^5^^^^1
 ;;^UTILITY(U,$J,358.3,8370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8370,1,2,0)
 ;;=2^FNA W/O IMAGE
 ;;^UTILITY(U,$J,358.3,8370,1,4,0)
 ;;=4^10021
 ;;^UTILITY(U,$J,358.3,8371,0)
 ;;=10022^^36^443^4^^^^1
 ;;^UTILITY(U,$J,358.3,8371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8371,1,2,0)
 ;;=2^FNA W/IMAGE
 ;;^UTILITY(U,$J,358.3,8371,1,4,0)
 ;;=4^10022
 ;;^UTILITY(U,$J,358.3,8372,0)
 ;;=76942^^36^443^3^^^^1
 ;;^UTILITY(U,$J,358.3,8372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8372,1,2,0)
 ;;=2^ECHO GUIDE FOR BIOPSY
 ;;^UTILITY(U,$J,358.3,8372,1,4,0)
 ;;=4^76942
 ;;^UTILITY(U,$J,358.3,8373,0)
 ;;=96372^^36^444^1^^^^1
 ;;^UTILITY(U,$J,358.3,8373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8373,1,2,0)
 ;;=2^THER/PROPH/DIAG INJ SC/IM
 ;;^UTILITY(U,$J,358.3,8373,1,4,0)
 ;;=4^96372
 ;;^UTILITY(U,$J,358.3,8374,0)
 ;;=96365^^36^444^3^^^^1
 ;;^UTILITY(U,$J,358.3,8374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8374,1,2,0)
 ;;=2^IV INFUSION UP TO 1HR
 ;;^UTILITY(U,$J,358.3,8374,1,4,0)
 ;;=4^96365
